Use of a Schelin Catheter for analgesia during Rezum treatment of the prostate.
Giampaolo SienaFrancesco SessaLuca CindoloPublished in: Prostate cancer and prostatic diseases (2023)
To further enhance the minimal invasiveness of Rezum treatment (RT), we sought to evaluate the advantages and feasibility of transurethral intraprostatic anesthesia (TUIA) via Schelin Catheter™ (SC). We enrolled 20 men with LUTS due to BPH, who underwent RT using TUIA via SC. Prior to the procedure, patients were asked to rate their pain on a numeric rating scale (NRS) numbered 0-10: with 0 being "No pain" and 10 being "Worst pain". Median NRS score ranged from 0 to 3. No perioperative procedure-related complications were reported.
Keyphrases
- chronic pain
- pain management
- benign prostatic hyperplasia
- neuropathic pain
- end stage renal disease
- lower urinary tract symptoms
- prostate cancer
- ultrasound guided
- newly diagnosed
- chronic kidney disease
- ejection fraction
- minimally invasive
- patients undergoing
- peritoneal dialysis
- cardiac surgery
- middle aged
- risk factors